Advertisement Pharmaceutical Business review - Page 69 of 5294 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 14, 2026

Pfizer partners with Enodia Therapeutics in $500m drug deal

Pfizer and Enodia Therapeutics have announced a research collaboration and licensing deal potentially worth over $500m to discover and develop Sec61 inhibitors.

Continue
Pfizer will take responsibility for clinical trials, manufacturing, regulatory submissions, and commercial operations once the collaboration phase concludes. Credit: ShU studio/Shutterstock.com.
October 14, 2026

Charles River partners with Magellan Stem Cells on cell therapy

Charles River will supply viral safety assessments using NGS for cell and gene therapy. Credit: Gorodenkoff/Shutterstock.com.
October 13, 2026

China’s NMPA clears Foresee’s Camcevi 42 mg for prostate cancer

Camcevi 42 mg is a ready-to-use, six-month subcutaneous depot formulation of leuprolide mesylate for advanced prostate cancer treatment. Credit: NMK-Studio/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Southern Research secures NIH funding for drug testing hub
  2. FDA approves Asahi Kasei’s Hovilpri for refractory HSV
  3. Perceptive, Nucleus partner to support radiopharmaceutical development
  4. Bio-Techne opens GMP small molecule facility in Bristol, UK
  5. Biohaven partners with Ono in $100m IgG degrader deal

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography